Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum. - Kawagoe R; Moriwaki T; Yamazaki K; Yukami H; Uetake H; Tsuda M; Suto T; Sugimoto N; Ojima H; Takii Y; Yasui H; Komoda M; et al. (International journal of clinical oncology, 2026)